{"id":"W2622353385","doi":"10.1002/hon.2438_80","title":"MINIMAL RESIDUAL DISEASE AND OUTCOMES IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) IN THE PHASE III GADOLIN TRIAL OF OBINUTUZUMAB AND BENDAMUSTINE VS BENDAMUSTINE","year":2017,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Bendamustine; Internal medicine; Minimal residual disease; Obinutuzumab; Population; Hazard ratio; Oncology; Gastroenterology; Follicular lymphoma; Surrogate endpoint; Bone marrow; Lymphoma; Confidence interval; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00195827,0.0003841772,0.0008433058,0.0001644548,0.0001561081,0.000552248,0.0003446378,0.0005513849,0.001047669],"category_scores_gemma":[0.001329725,0.0001939911,0.0005876555,0.0001834245,0.0003324109,0.0003600377,0.0002473208,0.0007904673,0.0001764062],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005962722,"about_ca_system_score_gemma":0.0003466016,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004261211,"about_ca_topic_score_gemma":0.0006100798,"domain_scores_codex":[0.9995735,0.0002416142,0.00003105073,0.00005757753,0.00004201838,0.00005416094],"domain_scores_gemma":[0.9993802,0.0001903045,0.0001977148,0.00004048109,0.00002758583,0.0001635622],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8741676,0.00260274,0.05796358,0.0005386557,0.001359047,0.0001260797,0.0001805169,0.001281657,0.01244569,0.0001045836,0.0008386779,0.04839111],"study_design_scores_gemma":[0.2666317,0.3873599,0.3286768,0.0002348205,0.003602674,0.0009900309,0.0001457653,0.002663639,0.005560677,0.0004644346,0.003620687,0.00004881874],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971653,0.002069743,0.0000797627,0.00008960729,0.00001695775,0.0001014781,0.000179564,0.000008379848,0.0002890455],"genre_scores_gemma":[0.998863,0.0002935113,0.0001110729,0.0001002095,0.00003308933,0.0001092234,0.0003047971,0.00000276078,0.0001822783],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00195827,"threshold_uncertainty_score":0.01035643,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05161901287869262,"score_gpt":0.3889514008878156,"score_spread":0.337332388009123,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}